Huntington's disease: a clinical review
- PMID: 21171977
- PMCID: PMC3022767
- DOI: 10.1186/1750-1172-5-40
Huntington's disease: a clinical review
Abstract
Huntington disease (HD) is a rare neurodegenerative disorder of the central nervous system characterized by unwanted choreatic movements, behavioral and psychiatric disturbances and dementia. Prevalence in the Caucasian population is estimated at 1/10,000-1/20,000. Mean age at onset of symptoms is 30-50 years. In some cases symptoms start before the age of 20 years with behavior disturbances and learning difficulties at school (Juvenile Huntington's disease; JHD). The classic sign is chorea that gradually spreads to all muscles. All psychomotor processes become severely retarded. Patients experience psychiatric symptoms and cognitive decline. HD is an autosomal dominant inherited disease caused by an elongated CAG repeat (36 repeats or more) on the short arm of chromosome 4p16.3 in the Huntingtine gene. The longer the CAG repeat, the earlier the onset of disease. In cases of JHD the repeat often exceeds 55. Diagnosis is based on clinical symptoms and signs in an individual with a parent with proven HD, and is confirmed by DNA determination. Pre-manifest diagnosis should only be performed by multidisciplinary teams in healthy at-risk adult individuals who want to know whether they carry the mutation or not. Differential diagnoses include other causes of chorea including general internal disorders or iatrogenic disorders. Phenocopies (clinically diagnosed cases of HD without the genetic mutation) are observed. Prenatal diagnosis is possible by chorionic villus sampling or amniocentesis. Preimplantation diagnosis with in vitro fertilization is offered in several countries. There is no cure. Management should be multidisciplinary and is based on treating symptoms with a view to improving quality of life. Chorea is treated with dopamine receptor blocking or depleting agents. Medication and non-medical care for depression and aggressive behavior may be required. The progression of the disease leads to a complete dependency in daily life, which results in patients requiring full-time care, and finally death. The most common cause of death is pneumonia, followed by suicide.
Similar articles
-
Juvenile Huntington's Disease: Diagnostic and Treatment Considerations for the Psychiatrist.Curr Psychiatry Rep. 2017 Feb;19(2):9. doi: 10.1007/s11920-017-0759-9. Curr Psychiatry Rep. 2017. PMID: 28168595 Review.
-
[Huntington's disease with childhood and adolescent onset: course of disease, clinical presentation and diagnostic challenges].Fortschr Neurol Psychiatr. 2020 Oct;88(10):661-667. doi: 10.1055/a-1082-6605. Epub 2020 May 5. Fortschr Neurol Psychiatr. 2020. PMID: 32369858 Review. German.
-
Psychiatric and cognitive difficulties as indicators of juvenile huntington disease onset in 29 patients.Arch Neurol. 2007 Jun;64(6):813-9. doi: 10.1001/archneur.64.6.813. Arch Neurol. 2007. PMID: 17562929
-
Junctophilin 3 (JPH3) expansion mutations causing Huntington disease like 2 (HDL2) are common in South African patients with African ancestry and a Huntington disease phenotype.Am J Med Genet B Neuropsychiatr Genet. 2015 Oct;168(7):573-85. doi: 10.1002/ajmg.b.32332. Epub 2015 Jun 16. Am J Med Genet B Neuropsychiatr Genet. 2015. PMID: 26079385 Free PMC article.
-
Echogenicity of basal ganglia structures in different Huntington's disease phenotypes.J Neural Transm (Vienna). 2015 Jun;122(6):825-33. doi: 10.1007/s00702-014-1335-7. Epub 2014 Dec 13. J Neural Transm (Vienna). 2015. PMID: 25503829
Cited by
-
Abnormal cerebellar volume and corticocerebellar dysfunction in early manifest Huntington's disease.J Neurol. 2015;262(4):859-69. doi: 10.1007/s00415-015-7642-6. Epub 2015 Jan 28. J Neurol. 2015. PMID: 25626721
-
Validation Study of a German Cognitive Battery for Huntington's Disease: Relationship Between Cognitive Performance, Functional Decline, and Disease Burden.Arch Clin Neuropsychol. 2021 Jan 15;36(1):74-86. doi: 10.1093/arclin/acaa038. Arch Clin Neuropsychol. 2021. PMID: 32613239 Free PMC article.
-
An apparent core/shell architecture of polyQ aggregates in the aging Caenorhabditis elegans neuron.Protein Sci. 2021 Jul;30(7):1482-1486. doi: 10.1002/pro.4105. Epub 2021 May 22. Protein Sci. 2021. PMID: 33966305 Free PMC article.
-
hiPSCs for predictive modelling of neurodegenerative diseases: dreaming the possible.Nat Rev Neurol. 2021 Jun;17(6):381-392. doi: 10.1038/s41582-021-00465-0. Epub 2021 Mar 3. Nat Rev Neurol. 2021. PMID: 33658662 Free PMC article. Review.
-
Recent approaches on Huntington's disease (Review).Biomed Rep. 2022 Nov 21;18(1):5. doi: 10.3892/br.2022.1587. eCollection 2023 Jan. Biomed Rep. 2022. PMID: 36544856 Free PMC article. Review.
References
-
- Bruyn GW. In: Handbook of Clinical Neurology. Vinken PJ, Bruyn GW, editor. Vol. 6. Elsevier Amsterdam; 1968. Huntington's chorea: historical, clinical and laboratory synopsis; pp. 298–378.
-
- Bates G, Harper P, Jones L. Huntington's disease. 3. Oxford, Oxford University press; 2002.
-
- van Duijn E, Kingma EM, van der Mast RC. Psychopathology in verified Huntington's disease gene carriers. J Neuropsychiatry Clin Neurosci. 2007;19:441–8. - PubMed
-
- Wheelock VL, Tempkin T, Marder K, Nance M, Myers RH, Zhao H, Kayson E, Orme C, Shoulson I. Huntington Study Group. Predictors of nursing home placement in Huntington disease. Neurology. 2003;60:998–1001. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical